It’s an assortment of reports clips that terrifies company executives. “Pharma Bro” Martin Shkreli pleading the Fifth Modification. Lawmakers are scolding the CEOs of Chrysler, Ford, and General Motors for flying non-public jets to hearings at which they’d plead for a $25 billion authority’s bailout. A committee chairman was imploring a witness accused of financial crimes to “attempt a trustworthy reply.”
It’s a pantheon of nationally televised company implosions that represents a worst-case — and more and more believable — situation for the pharmaceutical business Tuesday, when seven executives from main drug firms will testify earlier than the Senate Finance Committee in regards to the excessive price of prescription medicines. To keep away from the destiny of so many executives earlier than them, the pharmaceutical firms are shelling out for legal professionals, and strategic communications consultants who focus on instructing unpopular company figures natural methods to survive a Capitol Hill grilling.
STAT spoke with higher than a dozen company lobbyists, attorneys, and public relations consultants who laid out the intensive preparations that go into avoiding a cable-information disaster. Their recommendation’s central themes: seem contrite and prepared to work with lawmakers. Stay humble, even with senators who assault your compensation or lifestyle. And even within the face of aggressive questioning, by no means — by no mechanism! — push again with power.